Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed
Read More Pharma Industry News Ocugen reports promising interim results for OCU410 clinical trial in geographic atrophy Ocugen, Inc. has taken a significant step forward in the fight against geographic atrophy (GA) secondary to dry… byPallavi MadhirajuDecember 19, 2024